How were CYNA's earnings last quarter?

CYNA (NASDAQ:CYNA) posted its earnings results on Wednesday, August, 10th. The biotechnology company reported ($0.83) EPS for the quarter, missing the consensus estimate of ($0.77) by $0.06.

What other stocks do shareholders of CYNA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CYNA investors own include Corbus Pharmaceuticals (CRBP) , Synthetic Biologics (SYN) , Aralez Pharmaceuticals (ARLZ) , RedHill Biopharma (RDHL) , Zynerba Pharmaceuticals (ZYNE) , Catalyst Pharmaceuticals (CPRX) , National Grid (NG) , Protagonist Therapeutics (PTGX) and StoneMor (STON) .

CYNA (CYNA) raised $64 million in an IPO on Thursday, June 18th 2015. The company issued 4,500,000 shares at $14.18 per share. BofA Merrill Lynch served as the underwriter for the IPO and Nomura and Noble Life Science Partners were co-managers.

NASDAQ:CYNA

CYNA (CYNA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free CYNA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $40.48
▼
$40.48
50-Day Range: N/A
52-Week Range: $10.54
▼
$40.67

Volume: N/A
Average Volume: 113,889 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get CYNA alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About CYNA Stock (NASDAQ:CYNA)

Cynapsus Therapeutics Inc is a Canada-based specialty central nervous system (CNS) pharmaceutical company. It develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson’s disease (PD). The Company completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine. Apomorphine is the only molecule approved for acute, intermittent treatment of OFF episodes for advanced PD patients, but is currently only approved as a subcutaneous injection in the United States. APL-130277 is a turning ON medication designed to convert a PD patient from the OFF to the ON state while avoiding the issues associated with subcutaneous delivery of apomorphine. It is designed to convert all types of OFF episodes, including morning OFF episodes. Furthermore, the Company has initiated its pivotal Phase three clinical program for APL-130277.

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

CYNA Stock News Headlines

April 11, 2024 | msn.com

Amber Rose Responds to Chris Rock Dating Rumors, Reveals the A-List Actress She's Friends With (Exclusive)

November 30, 2023 | msn.com

Search underway for 2 men in Robeson Co. jewelry store robbery

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

October 27, 2023 | msn.com

Blac Chyna Opens Up About 'Custody Battle' with Tyga for Son King: 'Can't Wait Until It's Over'

October 21, 2023 | mirror.co.uk

BBC's Strictly Come Dancing's Neil Jones and fiancée put on loved up display

October 6, 2023 | msn.com

Blac Chyna reduced to selling clothes, purses for money amid legal battle with Tyga

October 5, 2023 | msn.com

Strictly Come Dancing's Katya Jones says 'you won't find us' after sending message to ex-husband over baby news

October 3, 2023 | msn.com

Blac Chyna selling her personal belongings ‘to make ends meet’ amid custody battle with Tyga

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

September 28, 2023 | msn.com

Blac Chyna Debuts Romance With Songwriter Derrick Milano

September 18, 2023 | msn.com

Blac Chyna Breaks Down In Emotional Reunion With Her Mom To Celebrate 1 Year Sobriety

September 15, 2023 | msn.com

Ciara Cracks Up Laughing When Asked About Co-Parenting With Ex-Fiancé Future

August 10, 2023 | msn.com

Blac Chyna Shares Rare Photo of Son King, 10, Honing Soccer Skills: 'Passionate About His Craft'

August 10, 2023 | msn.com

What sex tape scandal? Prince Kaybee set to release new single amid Cyan Boujee drama

August 2, 2023 | msn.com

NASA Wallops plans launch of Antares rocket to International Space Station

July 9, 2023 | startribune.com

Juanita Mary Martha 'Corky' (Corbett) Swartout

June 24, 2023 | msn.com

Eagles 'Excellent' Secondary Rankings: Best in NFL?

June 24, 2023 | msn.com

Troy Police Department blotter

June 14, 2023 | msn.com

To lawyers, Trump is a kryptonite client

June 14, 2023 | msn.com

2 men seriously injured following crash on H-3 Freeway in Kaneohe

June 13, 2023 | msn.com

Paul Heyman reveals that WWE already has the next John Cena under contract

June 6, 2023 | finance.yahoo.com

Vistagen Announces Stockholder-Approved Reverse Stock Split

May 24, 2023 | msn.com

Mile posts: Items on Tyrice Taylor, Aisha Ramone, Andrew Hutchinson, Ryan Harvey, Lily Campbell, Lexi Brown

May 5, 2023 | msn.com

Hypnotizing people before surgery becoming common worldwide

April 8, 2023 | msn.com

Lost dog found in South Carolina passes away after reuniting with owner 7 years later

March 15, 2023 | msn.com

Ababa pounds out superb 69, leads by 4

March 14, 2023 | msn.com

Peering Into Edison Intl's Recent Short Interest

See More Headlines

Receive CYNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CYNA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/10/2016
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:CYNA
Previous Symbol: OTCMKTS:CYNAF
CUSIP: N/A
CIK: 1532079
Web: www.cynapsus.ca
Phone: +1-416-7032449
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

CYNA Stock Analysis - Frequently Asked Questions

How were CYNA's earnings last quarter?: CYNA (NASDAQ:CYNA) posted its earnings results on Wednesday, August, 10th. The biotechnology company reported ($0.83) EPS for the quarter, missing the consensus estimate of ($0.77) by $0.06.
What other stocks do shareholders of CYNA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CYNA investors own include Corbus Pharmaceuticals (CRBP), Synthetic Biologics (SYN), Aralez Pharmaceuticals (ARLZ), RedHill Biopharma (RDHL), Zynerba Pharmaceuticals (ZYNE), Catalyst Pharmaceuticals (CPRX), National Grid (NG), Protagonist Therapeutics (PTGX) and StoneMor (STON).
When did CYNA IPO?: CYNA (CYNA) raised $64 million in an IPO on Thursday, June 18th 2015. The company issued 4,500,000 shares at $14.18 per share. BofA Merrill Lynch served as the underwriter for the IPO and Nomura and Noble Life Science Partners were co-managers.

This page (NASDAQ:CYNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CYNA (CYNA) Stock Price, News & Analysis

About CYNA Stock (NASDAQ:CYNA)

CYNA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

CYNA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info